Previous 10 | Next 10 |
2024-03-14 12:44:26 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips With the growing demand for telemedicine, the market could be worth about $450 billion by the time 2032 rolls around. That’s according to Emergen Research. By 2034, it could hit $8...
2024-03-12 16:33:15 ET Summary Hims & Hers Health, Inc. has grown from a startup ($82m revenues in 2019) to a multi-billion-dollar company ($872m revenues in 2023) with more than 1.5 million subscribers; showcasing its scalability and product development. Hims & Hers Healt...
Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced that members of the company’s management team will be participating in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024. All events wil...
2024-03-09 10:30:00 ET The telehealth industry took off during the early stages of the pandemic when it was pivotal for patients to be able to access remote care easily. But a big assumption many investors have made is that the growth won't be as promising now that things have largely retur...
2024-03-04 14:17:56 ET DENVER, Colo., Mar 04, 2024 ( 247marketnews.com )- Hims & Hers Health, Inc. (NYSE: HIMS ) set another new 52-week high, following its financial results report for the fourth quarter and full year 2023, and upbeat guidance for 2024. Hims & Hers set ...
2024-03-03 08:20:00 ET Shares of direct-to-consumer telehealth business Hims & Hers Health (NYSE: HIMS) are up 30% since the company reported its Q4 earnings. The little-known $2 billion company is grabbing investors' attention with eye-popping growth and rapidly improving finan...
2024-02-29 13:53:35 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips While telehealth stocks, once stars of the pandemic era, have seen a recent dip in investor interest, savvy investors recognize the sector’s bright future. Moreover, according to TalkS...
2024-02-27 10:45:00 ET In this video, I will be talking about Hims & Hers ' (NYSE: HIMS) recent earnings report and why the stock might still be a buy right now despite being up 25% this year already. *Stock prices used were from the trading day of Feb. 26, 2024. The video...
Hims & Hers Health, Inc. (NYSE: HIMS) is one of today's top gainers. The company's shares have moved 31.61% on the day to $13.49. Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a r...
2024-02-27 08:53:47 ET DENVER, Colo., Feb 27, 2024 ( 247marketnews.com )- Hims & Hers Health, Inc. (NYSE: HIMS ) reported, after yesterday’s market close, financial results for the fourth quarter and full year 2023 financial results, and upbeat guidance for 2024. Resu...
News, Short Squeeze, Breakout and More Instantly...
Hims & Hers Health Inc. Class A Company Name:
HIMS Stock Symbol:
NYSE Market:
Hims & Hers Health Inc. Class A Website:
Bringing experience from Novo Nordisk and Teva Pharmaceutical Industries, Schultz joins the Hims & Hers Board of Directors to help the company increase access to health and wellness solutions Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading hea...
2024-07-20 09:00:00 ET With shares up a blistering 150% year to date, Hims & Hers Health (NYSE: HIMS) boasts everything an investor could dream of these days: rapid expansion, a vast addressable market, and a reasonable valuation. Let's explore why it is my top growth ...
Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter financial results after the market closes on Monday, August 5, 2024. The company will host a live conference call to discuss the results at 5...